Commodore Capital’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.3M Sell
1,425,000
-493,970
-26% -$14.9M 2.93% 14
2026
Q1
$54.2M Buy
1,918,970
+29,525
+2% +$789K 3.14% 12
2025
Q4
$52.4M Sell
1,889,445
-529,031
-22% -$12.7M 3.49% 15
2025
Q3
$60.3M Buy
2,418,476
+507,043
+27% +$11.2M 2.95% 14
2025
Q2
$33.6M Hold
1,911,433
2.37% 16
2025
Q1
$30M Hold
1,911,433
2.21% 17
2024
Q4
$36.6M Hold
1,911,433
2.69% 15
2024
Q3
$35.4M Buy
1,911,433
+101,258
+6% +$1.85M 2.21% 16
2024
Q2
$34M Buy
1,810,175
+85,175
+5% +$1.73M 2.32% 15
2024
Q1
$39.9M Buy
1,725,000
+925,000
+116% +$24.6M 2.67% 13
2023
Q4
$22.4M Buy
+800,000
New +$16.2M 1.96% 19

Other funds holding PHVS

Commodore Capital's PHVS Position: Q2 2026 in Review

Commodore Capital reduced its Pharvaris (PHVS) stake by 26% in Q2 2026, selling an estimated $14.9M and leaving 1,425,000 shares worth $49.3M. The position accounts for 2.93% of the portfolio, ranked #14.

Commodore Capital first reported a position in PHVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $60.3M in Q3 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Commodore Capital held 1,425,000 shares of Pharvaris worth $49.3M as of Q2 2026.
  • Commodore Capital sold 493,970 Pharvaris shares in Q2 2026, an estimated $14.9M.
  • Pharvaris made up 2.93% of Commodore Capital's portfolio in Q2 2026, its #14 holding.
  • Commodore Capital first reported a position in Pharvaris in Q4 2023 and has held it in 11 quarters since.
  • Commodore Capital's Pharvaris position peaked at $60.3M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Commodore Capital's 13F filing for Q2 2026, filed 14 Aug 2026.